Verona Pharma plc (NASDAQ:VRNA) Q3 2024 Earnings Call Transcript November 4, 2024
Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, expectations were $-0.5.
Operator: Good morning, everyone, and welcome to Verona Pharma’s Third Quarter 2024 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode. Earlier this morning, Verona Pharma issued a press release announcing its financial results for the three months...
